Events › Healthcare & MedTech
Healthcare & MedTech
1,200
Attendees
Bio€quity Europe is the premier investment conference for the European life sciences ecosystem. It connects emerging biotechnology companies directly with core venture capital investors, private equity firms, and pharmaceutical business development and licensing (BD&L) executives to drive capital placement.
Exhibitor mix: The conference is strictly structured into a Presenting Company Track for emerging biotechs and high-level networking tracks for top venture capital (VC) firms and pharma BD&L executives.
Bio€quity Europe is held annually. This page tracks the next confirmed edition — Bio€quity Europe 2028 dates will be added here once announced.
Filter this event to your ICP.
Hundreds of exhibitors here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
⚠️ The exhibitor list for this event isn't publicly accessible yet. We'll work on it once you submit a request.
Venue
Bella Center CopenhagenConvention centre · 65,000 m² · 5 halls · ~12,000 people
Scandinavia's leading convention and exhibition center, located in Copenhagen, Denmark. It features over 65,000 sqm of event space, multiple halls, and 48 permanent meeting rooms, catering to large-scale trade shows, congresses, and events.
📍 Center Boulevard 5, 2300 København S, Denmark
Operated by Bellagroup
Organizer
BioCentury Inc. and EBD GroupPrivate · San Carlos, United States · Founded 1993
Co-organized event by BioCentury and EBD Group focused on partnering and investment for European biotech companies.
Why people attend
Venture capitalists and corporate development executives attend to source cross-border pipeline assets, vet emerging therapeutic platforms, and secure high-value co-investment partnerships.
Who attends
Exhibitor categories
Sample matches
Filtered to a Series-B SaaS ICP. Your filter will be different.
Sample Match A
example.com
"Strong ICP match: Series B, EU expansion, VP Engineering and CTO attending."
Sample Match B
example.io
"Mid-stage SaaS with active GTM motion; product-led growth signals align with ICP."
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
Speakers
115 speakers at Bio€quity Europe
BioCentury
Also speaking at 4th BioCentury Grand Rounds – U.S.
EBD Group
Also speaking at 4th BioCentury Grand Rounds – U.S.
VP & Editor in Chief · BioCentury Inc.
"Welcome & Introductions"
Also speaking at 4th BioCentury Grand Rounds – U.S.
CEO · Singapore National Research Foundation
"Welcome to Singapore"
Also speaking at 4th BioCentury Grand Rounds – U.S.
Chair of Asia Pacific and Strategic Advisor · Flagship Pioneering
"BioCentury Scene Setter: Asia’s Arc of Innovation"
Also speaking at 4th BioCentury Grand Rounds – U.S.
Founder & CEO · Nuance Pharma
"BioCentury Scene Setter: Asia’s Arc of Innovation"
Also speaking at 4th BioCentury Grand Rounds – U.S.
Managing Partner · Polaris Partners
"BioCentury Scene Setter: Asia’s Arc of Innovation"
Also speaking at 4th BioCentury Grand Rounds – U.S.
CEO · ClavystBio
"BioCentury Scene Setter: Asia’s Arc of Innovation"
Also speaking at 4th BioCentury Grand Rounds – U.S.
Assistant Chief Executive, Biomedical Research Council · A*STAR
"BioCentury Scene Setter: Asia’s Arc of Innovation"
Also speaking at 4th BioCentury Grand Rounds – U.S.
Managing Director · Biostate
"BioCentury Scene Setter: Asia’s Arc of Innovation"
Also speaking at BIO CEO & Investor Conference, 4th BioCentury Grand Rounds – U.S.
Senior Partner · Novo Holdings
"Regional Showcase: Why UK biotech is ready to breakout"
Also speaking at 4th BioCentury Grand Rounds – U.S.
Lead · Our Future Health
"Regional Showcase: Why UK biotech is ready to breakout"
Clinical Epidemiologist and Consultant in Acute Medicine. Global leader in population health.
Also speaking at Discovering Precision Medicines – ELRIG's Irish Forum, 4th BioCentury Grand Rounds – U.S.
CEO · Prokarium
"Regional Showcase: Why UK biotech is ready to breakout"
Also speaking at 4th BioCentury Grand Rounds – U.S.
Partner and co-Head of VC and Growth Capital · Herbert Smith Freehills
"Regional Showcase: Why UK biotech is ready to breakout"
Also speaking at 4th BioCentury Grand Rounds – U.S.
Head of Business Development · Clarke Energy
"Regional Showcase: Why UK biotech is ready to breakout"
Also speaking at The Distributed Energy Show 2026, Cruise Ship Interiors Design Expo Americas 2027, 4th BioCentury Grand Rounds – U.S.
VP & Head Corporate Venture Fund · UCB Ventures
"Regional Showcase: Why UK biotech is ready to breakout"
Also speaking at 4th BioCentury Grand Rounds – U.S.
+ 99 more speakers at this event.
More Healthcare & MedTech events
Frequently asked questions